Cite
MLA Citation
Helena A. Yu et al.. “Differences in the survival of patients with recurrent versus de novo metastatic KRAS‐mutant and EGFR‐mutant lung adenocarcinomas.” Cancer, vol. 121, no. 12, 2015, pp. 2078–2082. http://access.bl.uk/ark:/81055/vdc_100025911337.0x00001f